LCDX Caliber Imaging and Diagnostics Inc (CE)

The VivaScope® cellular imaging system developed by Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., was featured in a video segment and article posted on Fox News on October 29. VivaScope allows doctors to offer their patients noninvasive optical biopsies of skin and to aid in the detection of skin cancer. Since there is no cutting, there is also no possibility of infection or scarring.

The segment and article, titled "New technology performs skin biopsies without the cutting," note the benefits of noninvasive biopsy, and report that confocal microscopy has moved beyond the research stage and is being used to help physicians to diagnose patients quickly and painlessly. The segment and article also profile Dr. Babar Rao, director of Rao Dermatology in New York City, who notes that a scan of a lesion can be obtained within several minutes, and the images can be magnified to look for abnormal cells. The segment and article also depict VivaScope's use in examining a lesion on a three-year-old female patient. Furthermore, Dr. Rao remarks that the procedure is ideal if the patient has a mole on their face or breast, and expresses a hope that confocal microscopy will become "the x-ray of dermatology."

To view the video segment and read the article, please visit the following link:

www.foxnews.com/health/2013/10/29/new-technology-performs-skin-biopsies-without-cutting/

About Caliber Imaging & Diagnostics

Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.

VivaScope® is a registered trademark of Caliber Imaging & Diagnostics.

Safe Harbor

This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.

CONTACT: Richard Pulsifer
         Chief Financial Officer
         (617) 348-9821
         
         Investor Relations:
         Dian Griesel Inc.
         Cheryl Schneider
         (212) 825-3210
         cschneider@dgicomm.com
         
         Public Relations:
         Dian Griesel Inc.
         Susan Forman or Laura Radocaj
         (212) 825-3210
         sforman@dgicomm.com
         lradocaj@dgicomm.com